MapLight Therapeutics, Inc. (MPLT)
6.93
+0.71
(+11.41%)
USD |
NASDAQ |
Nov 06, 16:00
7.59
+0.66
(+9.52%)
After-Hours: 20:00
MapLight Therapeutics Total Long Term Debt (Quarterly) : 0.755M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.755M |
| March 31, 2026 | 4.671M |
| December 31, 2025 | 4.911M |
| September 30, 2025 | 5.144M |
| June 30, 2025 | 5.372M |
| Date | Value |
|---|---|
| March 31, 2025 | 5.59M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 5.294M |
| March 31, 2023 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cullinan Therapeutics, Inc. | 1.405M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |
| Sarepta Therapeutics, Inc. | 1.053B |